Particle morphology assessment is vital in the pharmaceutical industry, especially for protein-based biopharmaceuticals like monoclonal antibodies and therapeutic proteins. It involves analyzing the physical characteristics of particles, such as size, shape, and surface features, which can impact product stability, efficacy, and safety. For instance, particles can lead to aggregation, reducing a drug's effectiveness, or trigger immune responses, posing risks to patients.
-
PBID: 0230001500000237
-
1 A la gente le gusta esto.
-
0 Entradas
-
0 Fotos
-
0 Videos
-
Vista previa
-
Science and Technology
Buscar
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Actualizaciones Recientes
No data to show